Share Nigeria’s five listed pharmaceutical manufacturers increased capital expenditure by 81 percent to N29.26 billion in the first nine months of 2026, as companies ramp upSubscribe to keep reading Advertisement Share
You Might Also Like Acquisition costs, debt squeeze oil firms’ N525bn profit growth Nigeria’s cement makers report N1.71trn in profit on stronger margins, cost efficiencies UBA, Access, First HoldCo face fresh test as CBN dividend restrictions linger